ペンニードルの世界市場予測(~2026年):種類別(標準型ペンニードル、安全型ペンニードル)、長さ別(4mm、5mm、6mm、8mm、10mm、12mm)、治療法別(インスリン、GLP 1、成長ホルモン)、購入方法別(小売、非小売)

◆英語タイトル:Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP 1, Growth Hormone), and Mode of Purchase (Retail, Non-Retail) - Global Forecast to 2026
◆商品コード:MD2851
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2021年6月17日
◆ページ数:217
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

マーケッツアンドマーケッツ社はペンニードルの世界市場規模が2021年13億ドルから2026年22億ドルまで、年平均11.2%成長すると予想しています。本書では、世界のペンニードル市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、種類別(標準型ペンニードル、安全型ペンニードル)分析、長さ別(8MM、5MM、6MM、4MM、12MM)分析、治療別(インスリン療法、グルカゴン様ペプチド-1療法、成長ホルモン療法、その他治療法)分析、購入方法別(小売、非小売)分析、地域別分析、競争状況、企業情報などを整理しました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・ペンニードルの世界市場規模:種類別(標準型ペンニードル、安全型ペンニードル)
・ペンニードルの世界市場規模:長さ別(8MM、5MM、6MM、4MM、12MM)
・ペンニードルの世界市場規模:治療別(インスリン療法、グルカゴン様ペプチド-1療法、成長ホルモン療法、その他治療法)
・ペンニードルの世界市場規模:購入方法別(小売、非小売)
・ペンニードルの世界市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

“The pen needles market is expected to reach USD 2.2 Billion by 2026 from an estimated USD 1.3 Billion in 2021, at a CAGR of 11.2%.”
Growth in the market is largely driven by the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. On the other hand, the preference for alternative modes of drug delivery, poor reimbursement in developing countries, and needle anxiety are expected to restrain the overall market growth. The growing preference for biosimilar drugs and emerging markets are areas of opportunity in the market. The challenges faced by the market are reuse of pen needles and misuse of injection pens.

“Based on product type, the standard pen needles segment holds the largest market share during the forecast period.”
Based on type, the pen needles market is segmented into standard and safety pen needles. In 2020, the standard pen needles segment accounted for the largest share in the pen needles market. Standard pen needles are preferred over safety pen needles as they are more affordable, especially considering the need for daily insulin intake. The low cost of standard pen needles has also led to their wide adoption in emerging economies such as China, India, and Brazil, where the use of safety pen needles is low to negligible.

“Based on length, the 8mm segment grows at the highest market share during the forecast period.”
Based on length, the market is segmented into 4mm (5/32’’), 5mm (3/16’’), 6mm (1/4’’), 8mm (5/16’’), 10mm, and 12mm (1/2’’). In 2020, the 8mm segment accounted for the largest share in the pen needles market. The large share of this segment is mainly attributed to the wide adoption of these needles among diabetes patients.

“Based on mode of purchase, the retail segment is expected to register the highest CAGR during the forecast period.”
Based on the mode of purchase, the market is categorized into retail and non-retail. The retail segment accounted for the largest share and highest growth during the forecast period. The significant discounts offered on online/retail purchases of pen needles, high convenience, increasing awareness on pen needles, and the favorable reimbursement scenario in North America and Europe are some of the key factors driving the growth of the retail segment.

“Based on therapy, the insulin therapy segment is expected to register the highest CAGR during the forecast period.”
Based on therapy, the market is categorized into insulin therapy, glucagon-like peptide-1 (GLP-1) therapy, growth hormone therapy, and other therapies (osteoporosis, thyroid, obesity). In 2020, insulin therapy held maximum of the global pen needles market, primarily due to the high and growing diabetic population globally. This segment is also expected to grow at the highest rate during the forecast period.

“North America is expected to account for the largest share of the pen needles market in 2020.”
Geographically, the pen needles market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the pen needles market in 2020. The growing diabetes prevalence and favorable reimbursement scenario for pen needles, federal initiatives to create awareness about injection techniques, increasing market penetration by leading players, and the development of improved pen needle technologies are driving market growth in the US.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–60%, Tier 2–30%, and Tier 3–10%
• By Designation – C-level–30%, Director-level–50%, Others–20%
• By Region – North America–45%, Europe–15%, Asia Pacific–25%, Latin America- 10%, Middle East and Africa–5%

Key players in the Pen Needles Market:
The key players in the pen needles market include Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), Owen Mumford (UK), Terumo Corporation (Japan), Nipro Corporation (Japan) Allison Medical (US), AdvaCare Pharma (US), Berpu Medical Technology (China), ARKRAY (Japan), GlucoRx (UK), HTL-STREFA (Poland), UltiMed, (US), Hindustan Syringes and Medical Devices (India), Artsana Group (Italy), PromiseMed Diabetes Care (Canada), Montmed (Canada), Trividia Health (US), VOGT Medical Vertrieb (Germany), Van Heek Medical (Netherlands), Simple Diagnostics (US), Iyon (Turkey), Links Medical Products (US), and MHC Medical Products (US).

Research Coverage:
The report analyzes the pen needles market and aims at estimating the market size and future growth potential of this market based on various segments such as type, length, therapy, mode of purchase, and region. The report also includes a product portfolio matrix of various pen needles available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report:
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global pen needles market. The report analyzes this market by type, therapy, length, and mode of purchase.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global pen needles market.
• Market Development: Comprehensive information on the lucrative emerging markets by type, therapy, length, and mode of purchase.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global pen needles market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global pen needles market.

【レポートの目次】

1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 27
1.2.2 MARKET SEGMENTATION 28
1.2.3 YEARS CONSIDERED FOR THE STUDY 29
1.3 CURRENCY 29
1.3.1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 29
1.4 LIMITATIONS 30
1.5 STAKEHOLDERS 30
1.6 SUMMARY OF CHANGES 30
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DATA 32
FIGURE 1 RESEARCH DESIGN 32
2.1.1 SECONDARY DATA 32
2.1.1.1 Key data from secondary sources 34
2.1.2 PRIMARY DATA 34
FIGURE 2 PRIMARY SOURCES 34
2.1.2.1 Key data from primary sources 35
2.1.2.2 Key industry insights 36
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 36
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (PEN NEEDLES MARKET) 37
2.2 MARKET SIZE ESTIMATION 37
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 38
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: BECTON, DICKINSON AND COMPANY (2020) 38
FIGURE 7 REVENUE ANALYSIS OF THE TOP FIVE COMPANIES: PEN NEEDLES MARKET (2020) 39
FIGURE 8 DEMAND-SIDE ANALYSIS 40
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 41
FIGURE 10 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE PEN NEEDLES MARKET
(2021–2026) 41
FIGURE 11 TOP-DOWN APPROACH 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 43
FIGURE 12 MARKET DATA TRIANGULATION METHODOLOGY 43
2.4 MARKET SHARE ANALYSIS 43
2.5 ASSUMPTIONS FOR THE STUDY 44
2.6 RISK ASSESSMENT 44
TABLE 1 RISK ASSESSMENT: PEN NEEDLES MARKET 44
3 EXECUTIVE SUMMARY 45
FIGURE 13 PEN NEEDLES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 45
FIGURE 14 PEN NEEDLES MARKET, BY LENGTH, 2021 VS. 2026 (USD MILLION) 46
FIGURE 15 PEN NEEDLES MARKET, BY THERAPY, 2021 VS. 2026 (USD MILLION) 46
FIGURE 16 PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2021 VS. 2026 (USD MILLION) 47
FIGURE 17 GEOGRAPHIC SNAPSHOT: PEN NEEDLES MARKET 47
4 PREMIUM INSIGHTS 49
4.1 PEN NEEDLES MARKET OVERVIEW 49
FIGURE 18 GROWING PREVALENCE OF CHRONIC DISEASES TO DRIVE THE GROWTH OF THE PEN NEEDLES MARKET 49
4.2 ASIA PACIFIC: PEN NEEDLES MARKET, BY THERAPY AND COUNTRY 50
FIGURE 19 JAPAN DOMINATES THE APAC MARKET 50
4.3 PEN NEEDLES MARKET: GEOGRAPHIC MIX 51
FIGURE 20 INDIA & CHINA TO WITNESS THE HIGHEST GROWTH IN THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
FIGURE 21 PEN NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
5.2.1 DRIVERS 53
5.2.1.1 Growing prevalence of chronic diseases 53
FIGURE 22 NUMBER OF PEOPLE WITH CHRONIC CONDITIONS IN THE US,
1995–2030 (MILLION INDIVIDUALS) 53
FIGURE 23 ESTIMATED DIABETIC POPULATION, BY REGION, 2019 VS. 2030 VS. 2040 54
5.2.1.2 Favorable reimbursement in select countries 54
5.2.2 RESTRAINTS 54
5.2.2.1 Preference for alternative modes of drug delivery 54
5.2.2.2 Poor reimbursement scenario in developing countries 55
5.2.2.3 Needle anxiety 55
5.2.3 OPPORTUNITIES 55
5.2.3.1 Growing preference for biosimilar drugs 55
5.2.3.2 Emerging markets 56
TABLE 2 RISING INCOME LEVELS IN EMERGING COUNTRIES 56
5.2.4 CHALLENGES 56
5.2.4.1 Reuse of pen needles 56
5.2.4.2 Misuse of injection pens 57
5.3 PRICING ANALYSIS 57
TABLE 3 PRICING OF PEN NEEDLES AVAILABLE IN THE MARKET 58
5.4 VALUE CHAIN ANALYSIS 59
FIGURE 24 PEN NEEDLES MARKET: VALUE CHAIN ANALYSIS 59
5.5 ECOSYSTEM MARKET MAP 59
FIGURE 25 PEN NEEDLES MARKET: ECOSYSTEM MARKET MAP 60
5.6 PORTER’S FIVE FORCES ANALYSIS 60
TABLE 4 PEN NEEDLES MARKET: PORTER’S FIVE FORCES ANALYSIS 60
5.6.1 INTENSITY OF COMPETITIVE RIVALRY 60
5.6.2 BARGAINING POWER OF SUPPLIERS 61
5.6.3 BARGAINING POWER OF BUYERS 61
5.6.4 THREAT OF SUBSTITUTES 61
5.6.5 THREAT OF NEW ENTRANTS 62
5.7 SUPPLY CHAIN ANALYSIS 62
FIGURE 26 PEN NEEDLES MARKET: SUPPLY CHAIN ANALYSIS 63
5.8 REGULATORY ANALYSIS 64
5.8.1 NORTH AMERICA 64
5.8.1.1 US 64
TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION 64
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 64
5.8.1.2 Canada 64
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 65
FIGURE 27 CANADA: CLASS II MEDICAL DEVICE APPROVAL PROCESS 65
5.8.2 EUROPE 65
FIGURE 28 EUROPE: CE APPROVAL PROCESS FOR CLASS IIA MEDICAL DEVICES 66
5.8.3 ASIA PACIFIC 66
5.8.3.1 Japan 66
TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 66
5.8.3.2 China 67
TABLE 9 CHINA: REGULATORY BODIES APPOINTED FOR MEDICAL DEVICE APPROVAL 67
TABLE 10 CHINA: CLASSIFICATION OF MEDICAL DEVICES 67
5.8.3.3 India 68
5.9 IMPACT OF COVID-19 ON THE PEN NEEDLES MARKET 68
5.10 PATENT ANALYSIS 69
5.10.1 PATENT PUBLICATION TRENDS FOR PEN NEEDLES 69
FIGURE 29 PATENT PUBLICATION TRENDS (2011–MAY 2021) 69
5.10.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 69
FIGURE 30 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PEN NEEDLES PATENTS (JANUARY 2011–JUNE 2021) 70
FIGURE 31 TOP APPLICANT COUNTRIES/REGIONS FOR PEN NEEDLE PATENTS (JANUARY 2011–JUNE 2021) 71
5.11 TECHNOLOGY ANALYSIS 71
5.11.1 KEY TECHNOLOGY 71
5.11.1.1 Fluid flow enhancement technology 71
5.11.2 COMPLEMENTARY TECHNOLOGY 71
5.11.2.1 Microfabricated needles 71
5.11.3 ADJACENT TECHNOLOGY 72
5.11.3.1 Autoinjectors 72
6 PEN NEEDLES MARKET, BY TYPE 73
6.1 INTRODUCTION 74
TABLE 11 PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 74
TABLE 12 PEN NEEDLES MARKET, BY TYPE, 2019–2026 (MILLION UNITS) 74
6.2 STANDARD PEN NEEDLES 74
6.2.1 STANDARD PEN NEEDLES ARE PREFERRED OVER SAFETY PEN NEEDLES AS THEY ARE MORE AFFORDABLE 74
TABLE 13 STANDARD PEN NEEDLES OFFERED BY KEY PLAYERS 75
TABLE 14 STANDARD PEN NEEDLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 76
TABLE 15 STANDARD PEN NEEDLES MARKET, BY COUNTRY,
2019–2026 (MILLION UNITS) 77
6.3 SAFETY PEN NEEDLES 77
6.3.1 GROWING CONCERN OVER NEEDLESTICK INJURIES DRIVES THE GROWTH OF SAFETY PEN NEEDLES 77
TABLE 16 SAFETY PEN NEEDLES OFFERED BY KEY PLAYERS 78
TABLE 17 SAFETY PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 78
TABLE 18 SAFETY PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (MILLION UNITS) 79
7 PEN NEEDLES MARKET, BY LENGTH 80
7.1 INTRODUCTION 81
TABLE 19 PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 81
7.2 8MM 81
7.2.1 8MM PEN NEEDLES WILL CONTINUE TO DOMINATE THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD 81
TABLE 20 8MM PEN NEEDLES OFFERED BY KEY PLAYERS 81
TABLE 21 8MM PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 82
7.3 5MM 83
7.3.1 5MM PEN NEEDLES TO REGISTER SECOND-HIGHEST GROWTH RATE DURING THE STUDY PERIOD 83
TABLE 22 5MM PEN NEEDLES OFFERED BY KEY PLAYERS 83
TABLE 23 5MM PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 84
7.4 6MM 84
7.4.1 6MM PEN NEEDLES ARE THE MOST COMMONLY USED NEEDLES ACROSS THE GLOBE 84
TABLE 24 6MM PEN NEEDLES OFFERED BY KEY PLAYERS 85
TABLE 25 6MM PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 86
7.5 4MM 86
7.5.1 4MM PEN NEEDLES ARE EXPECTED TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 86
TABLE 26 4MM PEN NEEDLES OFFERED BY KEY PLAYERS 86
TABLE 27 4MM PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 87
7.6 12MM 88
7.6.1 THE POPULARITY OF SHORTER & LESS PAINFUL NEEDLES HAMPERS THE GROWTH OF THE 12MM PEN NEEDLES MARKET 88
TABLE 28 12MM PEN NEEDLES OFFERED BY KEY PLAYERS 88
TABLE 29 12MM PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 89
7.7 10MM 89
7.7.1 AVAILABILITY OF SHORTER PEN NEEDLES TO RESTRAIN THE GROWTH OF THE 10MM PEN NEEDLES MARKET 89
TABLE 30 10MM PEN NEEDLES OFFERED BY KEY PLAYERS 89
TABLE 31 10MM PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 90
8 PEN NEEDLES MARKET, BY THERAPY 91
8.1 INTRODUCTION 92
TABLE 32 PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 92
8.2 INSULIN THERAPY 92
8.2.1 RISING PREVALENCE OF DIABETES DRIVES THE GROWTH OF THE PEN NEEDLES MARKET FOR INSULIN THERAPY 92
TABLE 33 PEN NEEDLES MARKET FOR INSULIN THERAPY, BY COUNTRY,
2019–2026 (USD MILLION) 93
8.3 GLUCAGON-LIKE PEPTIDE-1 THERAPY 93
8.3.1 STRONG FOCUS OF MAJOR PHARMACEUTICAL COMPANIES TO INTRODUCE GLP-1 DRUGS TO DRIVE MARKET GROWTH 93
TABLE 34 PEN NEEDLES MARKET FOR GLP-1 THERAPY, BY COUNTRY,
2019–2026 (USD MILLION) 94
8.4 GROWTH HORMONE THERAPY 95
8.4.1 DEVELOPMENT OF SUSTAINED-RELEASE GROWTH HORMONE FORMULATIONS FOR REDUCING INJECTION FREQUENCY TO RESTRAIN THE GROWTH OF THE PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY 95
TABLE 35 PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION) 96
8.5 OTHER THERAPIES 96
TABLE 36 PEN NEEDLES MARKET FOR OTHER THERAPIES, BY COUNTRY,
2019–2026 (USD MILLION) 97
9 PEN NEEDLES MARKET, BY MODE OF PURCHASE 98
9.1 INTRODUCTION 99
TABLE 37 PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 99
9.2 RETAIL 99
9.2.1 RETAIL PURCHASES OF PEN NEEDLES TO WITNESS HIGH GROWTH IN THE COMING YEARS OWING TO THE GROWING POPULARITY OF ONLINE PURCHASES 99
TABLE 38 PEN NEEDLES MARKET FOR RETAIL PURCHASES, BY COUNTRY,
2019–2026 (USD MILLION) 100
9.3 NON-RETAIL 100
9.3.1 LARGE NUMBER OF NEEDLE-PHOBIC DIABETIC PATIENTS IS SUPPORTING THE GROWTH OF THIS SEGMENT 100
TABLE 39 INDICATIVE LIST OF REGULATIONS 101
TABLE 40 PEN NEEDLES MARKET FOR NON-RETAIL PURCHASES, BY COUNTRY,
2019–2026 (USD MILLION) 102
10 PEN NEEDLES MARKET, BY REGION 103
10.1 INTRODUCTION 104
TABLE 41 PEN NEEDLES MARKET, BY REGION, 2019–2026 (USD MILLION) 104
FIGURE 32 EMERGING COUNTRIES ARE EXPECTED TO WITNESS HIGHER GROWTH OVER THE FORECAST PERIOD 105
10.2 NORTH AMERICA 106
FIGURE 33 NORTH AMERICA: PEN NEEDLES MARKET SNAPSHOT 106
TABLE 42 NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 107
TABLE 43 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 107
TABLE 44 NORTH AMERICA: PEN NEEDLES MARKET, BY LENGTH,
2019–2026 (USD MILLION) 107
TABLE 45 NORTH AMERICA: PEN NEEDLES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 108
TABLE 46 NORTH AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 108
10.2.1 US 108
10.2.1.1 The US dominates the global pen needles market 108
FIGURE 34 TOTAL FERTILITY RATE IN THE US POPULATION (1990-2020) 109
TABLE 47 US: KEY MACROINDICATORS 110
TABLE 48 US: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 110
TABLE 49 US: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 110
TABLE 50 US: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 111
TABLE 51 US: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 111
10.2.2 CANADA 111
10.2.2.1 Unfavorable regulatory processes in Canada to restrain the market growth 111
TABLE 52 CANADA: KEY MACROINDICATORS 112
TABLE 53 CANADA: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 112
TABLE 54 CANADA: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 113
TABLE 55 CANADA: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 113
TABLE 56 CANADA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 113
10.3 EUROPE 114
TABLE 57 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 114
TABLE 58 EUROPE: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 114
TABLE 59 EUROPE: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 115
TABLE 60 EUROPE: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 115
TABLE 61 EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 115
10.3.1 GERMANY 116
10.3.1.1 High diabetes expenditure and reimbursement for pen needles is expected to drive the market in Germany 116
TABLE 62 GERMANY: KEY MACROINDICATORS 116
TABLE 63 GERMANY: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 117
TABLE 64 GERMANY: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 117
TABLE 65 GERMANY: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 117
TABLE 66 GERMANY: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 118
10.3.2 FRANCE 118
10.3.2.1 Favorable health insurance system to drive the pen needles market in France 118
TABLE 67 FRANCE: KEY MACROINDICATORS 118
TABLE 68 FRANCE: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 119
TABLE 69 FRANCE: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 119
TABLE 70 FRANCE: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 119
TABLE 71 FRANCE: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 120
10.3.3 UK 120
10.3.3.1 NHS support and access to cost-effective pen needles are likely to drive the market in the UK 120
TABLE 72 UK: KEY MACROINDICATORS 120
TABLE 73 UK: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 74 UK: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 121
TABLE 75 UK: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 121
TABLE 76 UK: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 122
10.3.4 ITALY 122
10.3.4.1 Regional variation in terms of coverage and benefits to hinder the market growth 122
TABLE 77 ITALY: KEY MACROINDICATORS 122
TABLE 78 ITALY: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 123
TABLE 79 ITALY: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 123
TABLE 80 ITALY: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 123
TABLE 81 ITALY: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 124
10.3.5 SPAIN 124
10.3.5.1 Supportive regulations mandating the use of safety pen needles to boost the growth of the Spanish market 124
TABLE 82 SPAIN: KEY MACROINDICATORS 125
TABLE 83 SPAIN: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 125
TABLE 84 SPAIN: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 125
TABLE 85 SPAIN: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 126
TABLE 86 SPAIN: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 126
10.3.6 REST OF EUROPE 126
TABLE 87 ROE: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 127
TABLE 88 ROE: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 127
TABLE 89 ROE: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 127
TABLE 90 ROE: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 128
10.4 ASIA PACIFIC 129
FIGURE 35 APAC: PEN NEEDLES MARKET SNAPSHOT 129
TABLE 91 APAC: PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 130
TABLE 92 APAC: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 130
TABLE 93 APAC: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 130
TABLE 94 APAC: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 131
TABLE 95 APAC: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 131
10.4.1 JAPAN 131
10.4.1.1 High diabetes incidence and supportive reimbursement policies to drive the market growth in Japan 131
TABLE 96 JAPAN: KEY MACROINDICATORS 132
TABLE 97 JAPAN: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 132
TABLE 98 JAPAN: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 132
TABLE 99 JAPAN: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 133
TABLE 100 JAPAN: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 133
10.4.2 CHINA 133
10.4.2.1 Large patient population and healthcare infrastructure improvements to drive the market growth in China 133
TABLE 101 CHINA: KEY MACROINDICATORS 134
TABLE 102 CHINA: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 134
TABLE 103 CHINA: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 135
TABLE 104 CHINA: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 135
TABLE 105 CHINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 135
10.4.3 AUSTRALIA AND NEW ZEALAND 136
10.4.3.1 Growing geriatric population in Australia and New Zealand to drive the pen needles market 136
TABLE 106 AUSTRALIA AND NEW ZEALAND: PEN NEEDLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 136
TABLE 107 AUSTRALIA AND NEW ZEALAND: PEN NEEDLES MARKET, BY LENGTH,
2019–2026 (USD MILLION) 136
TABLE 108 AUSTRALIA AND NEW ZEALAND: PEN NEEDLES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 137
TABLE 109 AUSTRALIA AND NEW ZEALAND: PEN NEEDLES MARKET,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 137
10.4.4 INDIA 137
10.4.4.1 Healthcare infrastructural improvements and implementation of favorable government initiatives support the market in India 137
TABLE 110 INDIA: KEY MACROINDICATORS 138
TABLE 111 INDIA: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 138
TABLE 112 INDIA: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 138
TABLE 113 INDIA: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 139
TABLE 114 INDIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 139
10.4.5 SOUTH KOREA 139
10.4.5.1 Growing chronic diseases in the geriatric population augments the growth of the pen needles market 139
TABLE 115 SOUTH KOREA: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 140
TABLE 116 SOUTH KOREA: PEN NEEDLES MARKET, BY LENGTH,
2019–2026 (USD MILLION) 140
TABLE 117 SOUTH KOREA: PEN NEEDLES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 140
TABLE 118 SOUTH KOREA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 141
10.4.6 SOUTHEAST ASIA 141
10.4.6.1 Growing awareness about diabetes drives the pen needles market 141
FIGURE 36 GROWING PREVALENCE OF DIABETES IN SOUTHEAST ASIA 141
FIGURE 37 HEALTHCARE EXPENDITURE (% GDP) IN SOUTHEAST ASIA (2018) 142
FIGURE 38 GERIATRIC POPULATION IN 2019 (% OF TOTAL POPULATION) 142
TABLE 119 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 142
TABLE 120 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY LENGTH,
2019–2026 (USD MILLION) 143
TABLE 121 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 143
TABLE 122 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 143
10.4.7 REST OF APAC 144
TABLE 123 ROAPAC: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 124 ROAPAC: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 144
TABLE 125 ROAPAC: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 144
TABLE 126 ROAPAC: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 145
10.5 LATIN AMERICA 145
TABLE 127 LATIN AMERICA: PEN NEEDLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 145
TABLE 128 LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 145
TABLE 129 LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH,
2019–2026 (USD MILLION) 146
TABLE 130 LATIN AMERICA: PEN NEEDLES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 146
TABLE 131 LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 146
10.5.1 BRAZIL 147
10.5.1.1 Brazil dominates the pen needles market in Latin America 147
TABLE 132 BRAZIL: KEY MACROINDICATORS 147
TABLE 133 BRAZIL: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 147
TABLE 134 BRAZIL: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 148
TABLE 135 BRAZIL: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 148
TABLE 136 BRAZIL: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 148
10.5.2 MEXICO 149
10.5.2.1 Increasing incidence of lifestyle-related disorders and rising awareness drive market growth in Mexico 149
TABLE 137 MEXICO: KEY MACROINDICATORS 149
TABLE 138 MEXICO: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 139 MEXICO: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 150
TABLE 140 MEXICO: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 150
TABLE 141 MEXICO: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 150
10.5.3 REST OF LATIN AMERICA 151
FIGURE 39 HEALTH EXPENDITURE IN LATIN AMERICAN COUNTRIES IN 2018 (% GDP) 151
TABLE 142 ROLA: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 151
TABLE 143 ROLA: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 152
TABLE 144 ROLA: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 152
TABLE 145 ROLA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 152
10.6 MIDDLE EAST AND AFRICA 153
10.6.1 INITIATIVES TO ENHANCE HEALTHCARE ACCESSIBILITY MAY SUPPORT MARKET GROWTH 153
TABLE 146 MEA: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 153
TABLE 147 MEA: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 154
TABLE 148 MEA: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 154
TABLE 149 MEA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 154
11 COMPETITIVE LANDSCAPE 155
11.1 OVERVIEW 155
11.2 KEY PLAYER STRATEGIES 155
11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 156
FIGURE 40 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE PEN NEEDLES MARKET 156
11.4 MARKET SHARE ANALYSIS 156
FIGURE 41 PEN NEEDLES MARKET SHARE, BY KEY PLAYER, 2020 157
11.5 COMPANY EVALUATION QUADRANT 158
11.5.1 STARS 158
11.5.2 EMERGING LEADERS 158
11.5.3 PERVASIVE PLAYERS 159
11.5.4 PARTICIPANTS 159
FIGURE 42 PEN NEEDLES MARKET: COMPANY EVALUATION QUADRANT (2020) 159
11.6 COMPANY EVALUATION QUADRANT FOR START-UPS 160
11.6.1 PROGRESSIVE COMPANIES 160
11.6.2 DYNAMIC COMPANIES 160
11.6.3 STARTING BLOCKS 160
11.6.4 RESPONSIVE COMPANIES 160
FIGURE 43 PEN NEEDLES MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS (2020) 161
11.7 COMPANY PRODUCT FOOTPRINT 162
TABLE 150 PRODUCT PORTFOLIO ANALYSIS: PEN NEEDLES MARKET 162
TABLE 151 PRODUCT PORTFOLIO ANALYSIS: PEN NEEDLES MARKET, BY LENGTH 163
TABLE 152 PRODUCT PORTFOLIO ANALYSIS: PEN NEEDLES MARKET, BY THERAPY 164
11.8 COMPANY GEOGRAPHIC FOOTPRINT 165
TABLE 153 GEOGRAPHIC REVENUE MIX: PEN NEEDLES MARKET (2020) 165
11.9 COMPETITIVE INTENSITY 166
11.9.1 EVALUATION PARAMETERS 166
TABLE 154 EVALUATION PARAMETERS & SCORES 166
11.9.2 SCORING METHODOLOGY FOR COMPETITIVE INTENSITY 168
FIGURE 44 SCORING METHODOLOGY FOR COMPETITIVE INTENSITY 168
11.9.3 COMPETITIVE INTENSITY SCORE, BY COMPANY 168
11.9.3.1 Competitive intensity score for BD 168
TABLE 155 COMPETITIVE INTENSITY FOR BD 168
11.9.3.2 Competitive intensity score for Novo Nordisk 169
TABLE 156 COMPETITIVE INTENSITY FOR NOVO NORDISK 169
11.9.3.3 Competitive intensity score for Ypsomed 170
TABLE 157 COMPETITIVE INTENSITY FOR YPSOMED 170
11.9.4 COMPETITIVE INTENSITY MAPPING: BD, NOVO NORDISK, AND YPSOMED 171
FIGURE 45 COMPARISONS OF COMPETITIVE INTENSITY SCORES: BD, NOVO NORDISK, AND YPSOMED 171
FIGURE 46 RELATIVE POSITIONING OF COMPANIES BASED ON COMPETITIVE INTENSITY SCORE AND PEN NEEDLE FOCUS 172
11.9.4.1 Product launches/technological advancements 173
FIGURE 47 BD HAS A HIGHER FOCUS ON INNOVATION FOR ITS PEN NEEDLES BUSINESS 173
11.9.4.2 Promotional/marketing activities 173
FIGURE 48 BD AND NOVO NORDISK SHOWCASE A HIGH FOCUS ON MARKETING & PROMOTIONAL ACTIVITIES 173
11.9.4.3 Sponsorships/donations/education/awareness campaigns 174
FIGURE 49 NOVO NORDISK A/S HAS A HIGH FOCUS ON DIABETES EDUCATION & AWARENESS 174
11.9.4.4 Certifications/accreditations/awards 174
FIGURE 50 BD, NOVO NORDISK, AND YPSOMED EQUALLY EXHIBIT HIGH COMPLIANCE WITH INDUSTRY STANDARDS 174
11.10 COMPETITIVE SCENARIO 175
11.10.1 PRODUCT LAUNCHES 175
TABLE 158 PRODUCT LAUNCHES (JANUARY 2018 – JUNE 2021) 175
11.10.2 DEALS 175
TABLE 159 DEALS (JANUARY 2018– JUNE 2021) 175
11.10.3 OTHER DEVELOPMENTS 176
TABLE 160 OTHER DEVELOPMENTS (JANUARY 2018– JUNE 2021) 176
12 COMPANY PROFILES 177
12.1 KEY PLAYERS 177
(Business overview, Products offered, Recent developments, MNM view)*
12.1.1 BECTON, DICKINSON AND COMPANY 177
TABLE 161 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 177
FIGURE 51 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020) 178
12.1.2 NOVO NORDISK A/S 181
TABLE 162 NOVO NORDISK A/S: BUSINESS OVERVIEW 181
FIGURE 52 NOVO NORDISK A/S: COMPANY SNAPSHOT (2020) 182
12.1.3 YPSOMED HOLDING AG 184
TABLE 163 YPSOMED HOLDING AG: BUSINESS OVERVIEW 184
FIGURE 53 YPSOMED HOLDING AG: COMPANY SNAPSHOT (2020) 185
12.1.4 B. BRAUN MELSUNGEN AG 187
TABLE 164 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW 187
FIGURE 54 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020) 188
12.1.5 TERUMO CORPORATION 190
TABLE 165 TERUMO CORPORATION: BUSINESS OVERVIEW 190
FIGURE 55 TERUMO CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.6 NIPRO CORPORATION 193
TABLE 166 NIPRO CORPORATION: BUSINESS OVERVIEW 193
FIGURE 56 NIPRO CORPORATION: COMPANY SNAPSHOT (2020) 194
12.1.7 OWEN MUMFORD 195
TABLE 167 OWEN MUMFORD: BUSINESS OVERVIEW 195
12.1.8 ARKRAY 197
TABLE 168 ARKRAY: BUSINESS OVERVIEW 197
12.1.9 ULTIMED 199
TABLE 169 ULTIMED: BUSINESS OVERVIEW 199
12.1.10 HINDUSTAN SYRINGES AND MEDICAL DEVICES 200
TABLE 170 HINDUSTAN SYRINGES AND MEDICAL DEVICES: BUSINESS OVERVIEW 200
12.1.11 MONTMED 201
TABLE 171 MONTMED: BUSINESS OVERVIEW 201
12.1.12 HTL-STREFA 202
TABLE 172 HTL-STREFA: BUSINESS OVERVIEW 202
12.1.13 ALLISON MEDICAL, INC. 204
TABLE 173 ALLISON MEDICAL: BUSINESS OVERVIEW 204
12.1.14 GLUCORX 205
TABLE 174 GLUCORX: BUSINESS OVERVIEW 205
12.1.15 BERPU MEDICAL TECHNOLOGY 206
TABLE 175 BERPU MEDICAL TECHNOLOGY: BUSINESS OVERVIEW 206
12.1.16 ADVACARE PHARMA 207
TABLE 176 ADVACARE PHARMA: BUSINESS OVERVIEW 207
12.1.17 ARTSANA GROUP 208
TABLE 177 ARTSANA GROUP: BUSINESS OVERVIEW 208
12.1.18 PROMISEMED DIABETES CARE 209
TABLE 178 PROMISEMED DIABETES CARE: BUSINESS OVERVIEW 209
12.1.19 TRIVIDIA HEALTH 210
TABLE 179 TRIVIDIA HEALTH: BUSINESS OVERVIEW 210
12.1.20 VOGT MEDICAL VERTRIEB 211
TABLE 180 VOGT MEDICAL VERTRIEB GMBH: BUSINESS OVERVIEW 211
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS 212
12.2.1 VAN HEEK MEDICAL 212
TABLE 181 VAN HEEK MEDICAL: COMPANY OVERVIEW 212
12.2.2 SIMPLE DIAGNOSTICS 213
TABLE 182 SIMPLE DIAGNOSTICS: COMPANY OVERVIEW 213
12.2.3 IYON 214
TABLE 183 IYON: COMPANY OVERVIEW 214
12.2.4 LINKS MEDICAL PRODUCTS 215
TABLE 184 LINKS MEDICAL PRODUCTS: COMPANY OVERVIEW 215
12.2.5 MHC MEDICAL PRODUCTS 215
TABLE 185 MHC MEDICAL PRODUCTS: COMPANY OVERVIEW 215
13 APPENDIX 216
13.1 DISCUSSION GUIDE 216
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 220
13.3 AVAILABLE CUSTOMIZATIONS 222
13.4 RELATED REPORTS 222
13.5 AUTHOR DETAILS 223



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ペンニードルの世界市場予測(~2026年):種類別(標準型ペンニードル、安全型ペンニードル)、長さ別(4mm、5mm、6mm、8mm、10mm、12mm)、治療法別(インスリン、GLP 1、成長ホルモン)、購入方法別(小売、非小売)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆